Related Experiment Video
Updated: Jul 1, 2025

07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
22.0K
Longitudinal brain changes in Parkinson's disease with severe olfactory deficit
Kazuya Kawabata1, Epifanio Bagarinao2, Klaus Seppi3
1Department of Neurology, Medical University Innsbruck, Innsbruck, Austria; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Parkinsonism & Related Disorders
|March 2, 2024
Summary
Parkinson's disease (PD) patients with anosmia (loss of smell) show greater brain atrophy. Concurrent REM sleep behavior disorder (RBD) accelerates these cortical changes, impacting cognitive function.
Area of Science:
- Neuroscience
- Neurology
- Neuroimaging
Background:
- Olfactory dysfunction and REM sleep behavior disorder (RBD) are linked to cognitive changes in Parkinson's disease (PD).
- The neurobiological basis for these associations, particularly patterns of neurodegeneration, is not fully understood.
- This study investigates longitudinal cortical changes in early PD with severe olfactory loss (anosmia), with and without probable RBD.
Purpose of the Study:
- To examine longitudinal cortical atrophy and thinning in early-stage PD patients.
- To compare these changes in individuals with severe olfactory deficit (anosmia) versus those without.
- To investigate the impact of concurrent probable RBD on cortical changes in anosmic PD patients.
Main Methods:
- Analysis of longitudinal MRI data from 134 de novo PD patients and 49 healthy controls over four years (Parkinson Progression Marker Initiative cohort).
- Utilized a linear mixed-effects model to assess changes in brain volume and cortical thickness.
- Patients were categorized based on olfactory function (UPSIT score ≤ 18 for anosmia) and presence of probable RBD.
Main Results:
- PD patients with anosmia showed significantly greater longitudinal declines in volume and thickness in the parahippocampal gyri and right transverse temporal gyrus compared to those without anosmia.
- Patients with concurrent anosmia and probable RBD exhibited more pronounced longitudinal declines in cortical volume and thickness.
- These accelerated changes in the anosmia + RBD group involved additional regions: bilateral precuneus, left inferior temporal gyrus, right paracentral gyrus, and right precentral gyrus.
Conclusions:
- Atrophy and thinning patterns in early PD with anosmia involve critical cognitive regions, potentially explaining the link between severe olfactory deficit and cognitive decline.
- Concurrent RBD appears to exacerbate the rate of cortical changes in Parkinson's disease.
- These findings suggest distinct neurodegenerative trajectories based on olfactory status and RBD in early PD.
Related Concept Videos
Olfactory Receptors: Location and Structure
9.2K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
9.2K
Olfaction
44.3K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
44.3K
Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K

